You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 247 Assessment of sensitivity to a PD-1 check point inhibitor and cisplatin in bladder cancer patient-derived xenografts with various levels of PD-L1 expression in HuCD34NCG mice

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
247 Assessment of sensitivity to a PD-1 check point inhibitor and cisplatin in bladder cancer patient-derived xenografts with various levels of PD-L1 expression in HuCD34NCG mice

 

Online download statistics by month:

Online download statistics by month: November 2020 to October 2024

AbstractFullPdf
Nov 202010009
Dec 20202904
Jan 20211004
Feb 20211003
Mar 20213206
Apr 20211204
May 2021203
Jun 2021004
Jul 2021004
Aug 2021005
Sep 2021005
Oct 202130026
Nov 202112013
Dec 2021600
Jan 20221200
Feb 20221203
Mar 20221201
Apr 20223603
May 20221806
Jun 20221204
Jul 20222805
Aug 20221802
Sep 20221406
Oct 20221405
Nov 20221005
Dec 2022800
Jan 20231201
Feb 20232400
Mar 20232402
Apr 20232401
May 20232801
Jun 2023601
Jul 20231406
Aug 20232000
Sep 20231003
Oct 20233603
Nov 20232601
Dec 20234601
Jan 20242400
Feb 20243402
Mar 20243001
Apr 20241001
May 20243001
Jun 20243105
Jul 20242203
Aug 20243807
Sep 20241003
Oct 20242006
Total9560179